BV vs INCY · P/E 421, rev $717.6M vs P/E 14, rev $5.14B
BrightView Holdings (BV) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
BrightView Holdings (BV) is a specialty business services company listed on NYSE.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported BV revenue for 2026-06-30 was $717.6M. Net income was $6.1M. Revenue was down 45.5% from 2026-03-31 to 2026-06-30. BV currently screens at market cap $1.18B and trailing P/E 421.0.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
BV currently screens at market cap $1.18B and trailing P/E 421.0. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the BV and INCY stock pages for the full models.
Not investment advice.